ISG15 Inhibits IFN-α-Resistant Liver Cancer Cell Growth

Hepatocellular carcinoma (HCC) is one of the most prevalent tumors worldwide. Interferon-α (IFN-α) has been widely used in the treatment of HCC, but patients eventually develop resistance. ISG15 ubiquitin-like modifier (ISG15) is a ubiquitin-like protein transcriptionally regulated by IFN-α which sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xin-xing, Chen, Han-chun, Khan, Md. Asaduzzaman, Xu, Ai-hua, Yang, Fu-lan, Zhang, Yun-yi, Zhang, Dian-zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762208/
https://www.ncbi.nlm.nih.gov/pubmed/24024201
http://dx.doi.org/10.1155/2013/570909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762208/
https://www.ncbi.nlm.nih.gov/pubmed/24024201
http://dx.doi.org/10.1155/2013/570909

Ejemplares similares